Palisade Bio, Inc. · NASDAQ:PALI
Finley John David exercised options for 3,227,384 Palisade Bio, Inc. shares (Form 4)
Traded Oct 6, 2026 · Filed Oct 7, 2026
On Oct 6, 2026, Finley John David (Director, CEO CFO) exercised options for 3,227,384 Palisade Bio, Inc. shares, leaving 1,944,690 shares. Filed Oct 7, 2026 (Form 4).
- Options exercised
- 3,227,384 shares
- Holding after
- 1,944,690 shares
- Trading plan
- No
- Role
- Director, CEO CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Common Stock | Option exercise | 3,227,384 | 3,356,672 | Direct | |
| Oct 6, 2026 | Common Stock | Shares withheld for tax | 1,411,982 | US$1.49 | 1,944,690 | Direct |
Source
Related
- Palisade Bio, Inc.
- Finley John David
- Palisade Bio, Inc. shareholders
- Form 4 · Finley John David · Aug 21, 2026
- Form 4 · Finley John David · Jul 8, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026